Tables and Figures

TABLE 2-1

 

Number of Subjects Required to Detect a Difference in Lung-Cancer Risk Due to DU Exposure,

 

11

TABLE 2-2

 

Number of Subjects Required to Detect a Difference in Serum Creatinine Concentration Due to DU Exposure,

 

12

TABLE 2-3

 

Number of Subjects Required to Detect an Increased Risk of Renal Disease Due to DU Exposure,

 

14

TABLE 3-1

 

Information in Available Datasets,

 

27

TABLE 3-2

 

Summary of DU Bioassay Results (2003-2007),

 

34

TABLE 4-1

 

Proposed Epidemiologic Study Designs to Assess Health Outcomes of Exposure to DU,

 

43

FIGURE 1-1

 

Stages of an epidemiologic study of DU exposure,

 

7



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement